IL4 and cancer: Of note was the report by Matchim et al. [13], who found that cytokine production (IFN-γ, TNF-α, and IL-4) had a large effect size (greater than 1) at 6- and 12-month follow-ups post-MBSR in early-stage cancer patients [31].